Soligenix, Inc.(SNGX)
盘后1.430.02+1.16%18:48 EST
1.41+0.07+5.22%
行情数据延迟15分钟
- 最新
- 推荐
暂无内容公司概况
公司名称Soligenix, Inc.所属市场NASDAQ成立日期- -员工人数- -办公地址- -邮政编码- -联系电话- -联系传真- -公司概况Soligenix, Inc.成立于1987年，是一家临床阶段生物制药公司，专注于开发产品，治疗癌症和严重的胃肠道疾病的治疗所产生的危及生命的副作用（仍然是一个未满足的医疗需求），以及开发多种生物防御疫苗和疗法。- 2025-11-19Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-11-07Form 10-Q - Quarterly report [Sections 13 or 15(d)]季度报告Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 2025-09-29Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-09-19Form S-1 - General form for registration of securities under the Securities Act of 1933招股说明书Form S-1 - General form for registration of securities under the Securities Act of 1933
- 2025-08-18Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-08-15Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-08-15Form 10-Q - Quarterly report [Sections 13 or 15(d)]季度报告Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 2025-07-31Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-06-20Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-06-20Form S-8 - Securities to be offered to employees in employee benefit plans员工持股计划Form S-8 - Securities to be offered to employees in employee benefit plans
- 2025-05-09Form 10-Q - Quarterly report [Sections 13 or 15(d)]季度报告Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 2025-03-28Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-03-21Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]年度报告Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
- 2025-02-10Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2024-11-08Form 10-Q - Quarterly report [Sections 13 or 15(d)]季度报告Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 分时
- 5日
- 日
- 周
- 月
数据加载中...
最高
1.43
今开
1.34
量比
0.80
最低
1.34
昨收
1.34
换手率
1.84%